Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9578 posts found.

simone_menne

Boehringer Ingelheim names Simone Menne new chief financial officer

June 10, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer Ingelheim

German drugmaker Boehringer Ingelheim has named Simone Menne as its new chief financial officer. The current CFO at Lufthansa will …
Appointment
lab

New high-risk treatment can halt MS, claim researchers

June 10, 2016 Research and Development multiple sclerosis, research

The results of a Phase II clinical trial, published in The Lancet, suggests that a new use of chemotherapy followed …
News

FDA committee recommends MSD’s c. diff prevention drug

June 10, 2016 Medical Communications, Research and Development, Sales and Marketing FDA, MSD, Merck, bezlotoxumab, committee, zinplava

The US Food and Drug Administration’s (FDA) antimicrobial drugs advisory committee has voted by 10 to 5, with one abstention, …
News

Novartis presents strong results in rare blood disorder trials

June 10, 2016 Medical Communications, Research and Development Jakavi, Novartis, Revolade, blood disorder

Novartis has released data from two late-stage trials for rare blood disorders, which showed that Javi (ruxolitinib) is superior to …
News
janssen_latest_logo_on_sign

Janssen says its immunotherapy daratumumab extends progression-free survival in combination study to treat multiple myeloma

June 10, 2016 Medical Communications, Research and Development Janssen, Phase III trials, drug trial, immunotherapy, multiple myeloma

Janssen said late-stage combination trials for its immunotherapy daratumumab increased progression-free survival for patients with multiple myeloma.  The company said …
News

Nice says Bayer’s Eylea not recommended as first-line treatment in draft recommendation

June 10, 2016 Medical Communications, Research and Development Bayer, Eylea, NICE, recommendation, regulation

The National Institute for Health and Care Excellence (Nice) in a provisional guidance said Bayer’s (ETR: BAYN) Eylea (aflibercept) is …
News

Amgen, Novartis migraine drug meets primary endpoint in Phase II study

June 9, 2016 Research and Development AMG 334, Amgen, Novartis, Phase II, chronic, erenumab, migraine

A new treatment for chronic migraine prevention, co-developed by Novartis (NYSE: NVS) and Amgen (NASDAQ: AMGN), showed a statistically significant …
News
lab

GSK, Janssen RA treatment meets co-primary endpoints in Phase III trial

June 9, 2016 Research and Development GSK, Janssen, eular 2016, rheumatoid arthritis, sirukumab

GSK (LSE: GSK) and Janssen, a division of Johnson and Johnson, have announced data from a pivotal Phase III study …
News

Sandoz biosimilars as safe and efficacious as originators, says early trials data

June 9, 2016 Research and Development Enbrel, MabThera, Novartis, Sandoz, biosimilars, etanercept, rituximab

Sandoz, a division of Novartis, has presented data at the Annual European Congress of Rheumatology (EULAR 2016) demonstrating the safety …
News

AstraZeneca sells rights to anaesthetics products to Aspen for $520 million upfront

June 9, 2016 Research and Development, Sales and Marketing AstraZeneca, Licencing, anaesthetics, aspen, marketing agreement

UK drug firm AstraZeneca (LSE: AZN) on Thursday said it has agreed to sell rights for its anaesthetics portfolio to Aspen …
News
samsung

New data on biosimilars of the big three anti-TNF drugs presented at EULAR 2016

June 8, 2016 Research and Development, Sales and Marketing Benepali, Biogen, Enbrel, Flixabi, Humira, Remicade, Samsung Bioepis, biosimilars, eular 2016, sb5

Samsung Bioepis has presented data at EULAR 2016 on three biosimilars of the highly selling anti-TNF drugs Remicade (infliximab), Enbrel …
News
cipla

India-based Cipla gets new chief financial officer

June 8, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cipla, Dr Reddy's, cfo, dr reddys

Cipla (NSE: CIPLA) has poached a top executive from Dr. Reddy’s by naming Kedar Upadhye as its new global chief …
Appointment
novartis_side_building

Novartis to compare Cosentyx with Humira in new clinical trials

June 8, 2016 Research and Development Cosentyx, Humira, Novartis, comparison, eular 2016

Novartis has announced that it plans to directly compare Cosentyx (secukinumab) versus Humira (adalimumab) in patients with ankylosing spondylitis and …
News
biogen_austria_238

Biogen MS drug misses primary endpoint in Phase II trial

June 8, 2016 Research and Development Biogen, MS, multiple sclerosis, opicinumab

Biogen has reported top-line results in the Phase II trial evaluating opicinumab (anti-Lingo-1) in relapsing forms of multiple sclerosis, with …
News
stocks3

Losses and profit forecast cuts send shares tumbling again at Valeant

June 8, 2016 Research and Development, Sales and Marketing Shares, Valeant, cut, forecast, tumbling

Valeant Pharmaceuticals has published its results for the first quarter, which has seen the firm post a net loss of …
News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026